MassMutual Private Wealth & Trust’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-31	Closed	-$1K	–	1674
2021 Q4	$1K	Hold	31	–	–	﹤0.01%	1357
2021 Q3	$0	Buy	+31	New	+$496	﹤0.01%	1363
2016 Q1	–	Sell	-25	Closed	-$2.95K	–	919
2015 Q4	$3.73K	Buy	+25	New	+$4.23K	﹤0.01%	605
2015 Q2	–	Sell	-572	Closed	-$161K	–	836
2015 Q1	$161K	Buy	+572	New	+$124K	0.03%	298

Other funds holding ICPT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MassMutual Private Wealth & Trust's ICPT Position: Q1 2022 in Review

MassMutual Private Wealth & Trust sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2022, closing a stake of 31 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in ICPT in Q1 2015 and held it in 4 quarters. The position peaked at $161K in Q1 2015. 148 funds tracked by Wall St. Rank hold ICPT as of Q1 2022.

MassMutual Private Wealth & Trust reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 31 Intercept Pharmaceuticals, Inc. shares in Q1 2022, an estimated $1K.
MassMutual Private Wealth & Trust first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 4 quarters.
MassMutual Private Wealth & Trust's Intercept Pharmaceuticals, Inc. position peaked at $161K in Q1 2015.
148 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2022, filed 8 Apr 2022.